Tag: ADR

Adherium HGE Health Care Hailie ASX ADR asthma chronic obstructive pulmonary disease copd

Adherium joins forces with US health group to offer remote medical management for high-risk respiratory patients

New Zealand-based Adherium (ASX: ADR) is set to form a collaborative alliance with US-based HGE Health to remotely evaluate, treat and manage patients with severe asthma and chronic obstructive pulmon...
Adherium ASX ADR FDA Smartinhaler United States AstraZeneca Symbicort

Adherium receives FDA grant to market Smartinhaler in the US

Medical device manufacturer Adherium (ASX: ADR) has secured a crucial go-ahead decision from the Food and Drug Administration (FDA) in the US. Earlier today, Adherium was granted 510(k) clearance f...
Adherium ASX ADR directors on market share purchase

Adherium directors rally around internal mission to progress Smartinhaler technology

Medical device manufacturer Adherium (ASX: ADR) has highlighted its own optimism and confidence regarding its progress in developing a novel way for delivering drug treatments to patients. Adherium...
Adherium ASX ADR Smartinhaler asthma

Adherium looks to jumpstart medication uptake rates via Smartinhaler

Medical device manufacturer Adherium (ASX: ADR) is working on a potentially seismic shift in how medicine is consumed by patients. In a presentation to the Joint Congress of the American Academy of...